Tara Lynn Kieffer insider trades

Open-market stock purchases and sales by Tara Lynn Kieffer, Chief Product Strategy Officer at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since Dec 7, 2020.

Recent trades

DateStockTradeValue
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncSold (not open market)$46.4K
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Dec 5, 2025ENTA Enanta Pharmaceuticals IncSold$30K
Dec 1, 2025ENTA Enanta Pharmaceuticals IncSold (not open market)$10.6K
Nov 25, 2025ENTA Enanta Pharmaceuticals IncBought (not open market)—

Companies traded

  • ENTA Enanta Pharmaceuticals Inc: 4 sales, last Feb 12, 2026

Get free alerts when Tara Lynn Kieffer files a new trade →